The image shows how the spike protein increases the levels of Iba-1 protein in brain-resident immune cells known as microglia. This protein is a marker (an indicator) for the activation of these ...
Many lessons learned from past research were immediately applicable to SARS-CoV-2 vaccine design, because its spike protein is a class I fusion glycoprotein analogous to those of other beta-corona ...
14d
News Medical on MSNNatural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergenceFindings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance protection against reinfection.
16d
News Medical on MSNIn silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domainAnnouncing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary ...
TIME ELAPSED: 6–11 DAYS The Virus Takes Countermeasures SARS-CoV-2 uses several tactics to thwart the immune system’s response. Tactic 1: The virus spike may camouflage itself with sugar ...
The following is a summary of “Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis,” published in ...
Researchers from the Institute of Science Tokyo and Osaka Medical and Pharmaceutical University said that they have developed a peptide that can bind to the spike proteins of SARS-CoV-2 to prevent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results